- Products & Services
- R & D
- Quality & Environmental Policy
- Corporate Profile
- July.19,2019
- LSI Medience Joins the Global Diagnostics Network (GDN)
- May.14,2019
- Notice Regarding “Life Science Institute Reaches Agreement on Strategic Capital Partnership with PHC Holdings” Announced by Life Science Institute, Inc.
- May.4,2018
- Initiation of a Japanese Cancer Patient-derived Xenograft (J-PDX) Repository Establishment Program
- Aug.3,2017
- Provision of the first centralized clinical laboratory testing service in the Philippines
- May.2,2014
- Announcement of Business Alliance between Nikon and LSI Medience
- Feb.6,2014
- Mitsubishi Chemical Medience Corporation Announces New Company Name and New Head Office
- Sep.17,2013
- Mitsubishi Chemical Medience Starts Up Evaluating the Usefulness of Glycomics Analysis Services for Glycosylated Biologics and Biosimilars - Mitsubishi Chemical Medience Enters into an Exclusive License Agreement of Energy Resolved Oxonium Ion Monitoring (Erexim) Technology -
- Jun.21,2013
- Mitsubishi Chemical Medience and LabCorp Clinical Trials Announce Master Service Agreement to Offer Clients Greater Access to Global Central Lab Services
- Oct.31,2011
- Mitsubishi Chemical Medience Corporation launches PATHFAST Analyzer in U.S. market
- Jun.17,2011
- Mitsubishi Chemical Medience Corporation Receives 510(k) Clearance for PATHFAST cTnI-II (cardiac Troponin I) Test in U.S.
We provide IVD instruments & reagents , clinical Testing & services.
Central laboratory, bio-analysis services and evaluating the safety of chemicals.
We offer a series of safety, pharmacology, and pharmacokinetic studies from discovery of pharmaceutical products and regenerative medicines to approval application.
We support the food industry through assuring the safety and reliability of food products.
